IL-23 Inhibitors and Other Emerging Psoriasis Treatments
The IL-23 Inhibitors and Other Emerging Psoriasis Treatments webcast will discuss emerging treatments for psoriasis along with IL-23.
Faculty: Kenneth B. Gordon, MD, Medical College of Wisconsin
The video was produced by the Cleveland Clinic Foundation Center for Continuing Education and the Dermatology and Plastic Surgery Institute.
Interested in related CME education? Visit http://www.ccfcme.org
Видео IL-23 Inhibitors and Other Emerging Psoriasis Treatments канала ClevelandClinicCME
Faculty: Kenneth B. Gordon, MD, Medical College of Wisconsin
The video was produced by the Cleveland Clinic Foundation Center for Continuing Education and the Dermatology and Plastic Surgery Institute.
Interested in related CME education? Visit http://www.ccfcme.org
Видео IL-23 Inhibitors and Other Emerging Psoriasis Treatments канала ClevelandClinicCME
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
New Biologic Therapies that Target the IL-12/23 Pathway
Psoriasis: Translating Current and Emerging Therapies into Enhanced Management Strategies
Use of IL-23 Inhibitors to Treat Plaque Psoriasis
Psoriatic Arthritis
Advances in Anti-Cytokine Therapy: New Pathways (IL 12/23, IL17, IL23)
Managing Acute and Chronic Gout -- From Simple to Complex
Psoriasis - causes, symptoms, diagnosis, treatment, pathology
Jim Krueger: T-Cells and Psoriasis
Positioning anti-IL-12 and anti-IL-23 inhibitors
Update in Treatment of Psoriatic Arthritis
The Autoinflammatory Syndromes: All Who Fever Are Not Infected
What is Psoriasis? Definition, Etiology, Classification, Pathophysiology, Diagnosis, Treatment
Dr.Gobind Rai Garg discusses the topic - Tildrakizumab
Advances in Psoriatic Arthritis and Spondyloarthropathy
Understanding the use of IL12/IL23 targeted biologics
IL-17 Inhibitors
Microbiome and Autoimmunity
IL6 in Health and Disease
TNF-Inhibitors: “Classic” Biologics for Psoriatic Disease
Psoriasis and beyond: targeting the IL-17 pathway